Put Options Transactions Made in Q4 2023 in Brainstorm Cell Therapeutics Inc. (BCLI)
This table provides information about the institutional ownership of Brainstorm Cell Therapeutics Inc. (BCLI) during Q4 2023. The information is specifically focused on institutions that hold put options of BRAINSTORM CELL THERAPEUTICS INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Adar1 Capital Management, LLC
Austin, TX |
BUY
|
PUT |
101KNew |
$15.1K - $40.3K
|
101K
$174K
|
|
|
Feb 14, 2024
Q4 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
PUT |
24.7K+ 100.41% |
$3.71K - $9.88K
|
49.3K
$85.3K
|
|
|
Feb 15, 2024
Q4 2023
|
Barclays PLC
London, X0 |
BUY
|
PUT |
23.2KNew |
$3.48K - $9.28K
|
23.2K
$40.1K
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
PUT |
-77.9K- 96.77% |
$11.7K - $31.2K
|
2.6K
$4.5K
|